93 related articles for article (PubMed ID: 1058840)
1. Lymphocyte stimulation by autologous tumor cells in the presence of serum from the same patient or from healthy donors.
Vánky F; Klein E; Stjernswärd J; Trempe G
Int J Cancer; 1975 Nov; 16(5):850-60. PubMed ID: 1058840
[TBL] [Abstract][Full Text] [Related]
2. The immune-status in patients with bone and soft-tissue sarcomas.
Kotz R; Rella W; Salzer M
Recent Results Cancer Res; 1976; (54):197-205. PubMed ID: 1070721
[TBL] [Abstract][Full Text] [Related]
3. Cellular immunity against tumor-associated antigens in humans: lymphocyte stimulation and skin reaction.
Vánky R; Klein E; Stjernswärd J; Nilsonne U
Int J Cancer; 1974 Aug; 14(2):277-88. PubMed ID: 4376515
[No Abstract] [Full Text] [Related]
4. Human tumor-lymphocyte interaction in vitro. III. T lymphocytes in autologous tumor stimulation (ATS).
Vánky F; Klein E; Stjernswärd J; Rodriguez L; Péterffy A; Steiner L; Nilsonne U
Int J Cancer; 1978 Dec; 22(6):679-86. PubMed ID: 309867
[TBL] [Abstract][Full Text] [Related]
5. Human tumor--lymphocyte interaction in vitro: blastogenesis correlated to detectable immunoglobulin in the biopsy.
Vánky F; Trempe G; Klein E; Stjernswärd
Int J Cancer; 1975 Jul; 16(1):113-24. PubMed ID: 1080747
[TBL] [Abstract][Full Text] [Related]
6. Lymphocyte blastogenic responses to cultured allogeneic tumor cells in vitro.
Anderson RJ; McBride CM; Hersh EM
Cancer Res; 1972 May; 32(5):988-92. PubMed ID: 4336032
[No Abstract] [Full Text] [Related]
7. Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor.
Brooks WH; Netsky MG; Normansell DE; Horwitz DA
J Exp Med; 1972 Dec; 136(6):1631-47. PubMed ID: 4345108
[TBL] [Abstract][Full Text] [Related]
8. Correlation between lymphocyte-mediated auto-tumor reactivities and clinical course. I. Evaluation of 46 patients with sarcoma.
Vánky F; Willems J; Kreicbergs A; Aparisi T; Andréen M; Broström LA; Nilsonne U; Klein E; Klein G
Cancer Immunol Immunother; 1983; 16(1):11-6. PubMed ID: 6605799
[TBL] [Abstract][Full Text] [Related]
9. The response to phytohaemagglutinin (PHA) of lymphocytes from cancer patients.
Kumar S; Taylor G
J Clin Pathol; 1973 Jul; 26(7):476-9. PubMed ID: 4727057
[TBL] [Abstract][Full Text] [Related]
10. Immune responses in patients with brain tumors. Factors such as anti-convulsants that may contribute to impaired cell-mediated immunity.
Neuwelt EA; Kikuchi K; Hill S; Lipsky P; Frenkel EP
Cancer; 1983 Jan; 51(2):248-55. PubMed ID: 6821814
[TBL] [Abstract][Full Text] [Related]
11. Serum antibodies against the heat shock protein 60 are elevated in patients with osteosarcoma.
Trieb K; Gerth R; Windhager R; Grohs JG; Holzer G; Berger P; Kotz R
Immunobiology; 2000 Jan; 201(3-4):368-76. PubMed ID: 10776793
[TBL] [Abstract][Full Text] [Related]
12. Anti-EGFR antibody cetuximab enhances the cytolytic activity of natural killer cells toward osteosarcoma.
Pahl JH; Ruslan SE; Buddingh EP; Santos SJ; Szuhai K; Serra M; Gelderblom H; Hogendoorn PC; Egeler RM; Schilham MW; Lankester AC
Clin Cancer Res; 2012 Jan; 18(2):432-41. PubMed ID: 22090361
[TBL] [Abstract][Full Text] [Related]
13. Human intracranial tumors: effect of autologous serum addition on leucocyte migration inhibition.
Böker DK
Acta Neurochir (Wien); 1982; 65(3-4):227-37. PubMed ID: 7180599
[TBL] [Abstract][Full Text] [Related]
14. Human liver passenger cells suppress autologous and allogeneic blood lymphocytes proliferation.
Lukomska B; Winnock M; Balabaud C; Saric J; Polanski J; Olszewski WL
Transplant Proc; 1997; 29(1-2):1105-7. PubMed ID: 9123220
[No Abstract] [Full Text] [Related]
15. Cellular immunity to human sarcoma.
Vánky F; Stjernswärd J; Nilsonne U
J Natl Cancer Inst; 1971 Jun; 46(6):1145-51. PubMed ID: 4932427
[No Abstract] [Full Text] [Related]
16. Reactivity of human lymphocytes against autochthonous and allogeneic normal and tumor cells in vitro.
Chu EH; Stjernswärd J; Clifford P; Klein G
J Natl Cancer Inst; 1967 Oct; 39(4):595-617. PubMed ID: 18623923
[TBL] [Abstract][Full Text] [Related]
17. The human mixed lymphocyte-tumor cell interaction test. I. Positive autologous lymphocyte proliferative responses can be stimulated by tumor cells as well as by cells from normal tissues.
Grimm EA; Vose BM; Chu EW; Wilson DJ; Lotze MT; Rayner AA; Rosenberg SA
Cancer Immunol Immunother; 1984; 17(2):83-9. PubMed ID: 6205746
[TBL] [Abstract][Full Text] [Related]
18. [Immunological monitoring of brain tumors--prognosis based on T-lymphocyte subpopulations and skin testing for delayed hypersensitivity].
Yokoyama H; Nakadai M; Asou Y; Maeda T; Ogashiwa M; Takeuchi K
No To Shinkei; 1985 Feb; 37(2):193-9. PubMed ID: 3873952
[TBL] [Abstract][Full Text] [Related]
19. Lysis of tumor biopsy cells by blood lymphocyte subsets of various densities. Autologous and allogeneic studies.
Vánky F; Masucci MG; Bejarano MT; Klein E
Int J Cancer; 1984 Feb; 33(2):185-92. PubMed ID: 6693199
[TBL] [Abstract][Full Text] [Related]
20. [Reconstitution of peripheral blood lymphocytes in patients treated with bone marrow transplantation: comparison between allogeneic and autologous transplantation].
Parra C; Roldán E; Rodríguez C; Pérez de Oteyza J; Oteho E; López J; Maldonado MS; García Laraña J; Muñoz A; Odriozola J; Brieva JA
Med Clin (Barc); 1999 Jun; 113(1):1-5. PubMed ID: 10422068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
